Endostar, an Anti-angiogenesis Inhibitor, Combined with Chemoradiotherapy for Locally Advanced Cervical Cancer

In conclusion, CCRT plus Endostar significantly improved DMFS but not PFS over CCRT alone. The addition of Endostar could significantly improve survival for patients with positive VEGFR2 expression.PMID:34544526 | DOI:10.3727/096504021X16318716607908
Source: Oncology Research - Category: Cancer & Oncology Authors: Source Type: research